CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: Overview and take-home messages

Gastroenterology

Volumn 144, Issue 3, 2013, Pages 478-481

  Kanwal, Fasiha ^a   Lok, Anna S ^b   El Serag, Hashem B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; CANCER SCREENING; CLINICAL PRACTICE; COLON CANCER; DISEASE SURVEILLANCE; DRUG USE; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; HEALTH CARE QUALITY; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; MORBIDITY; MORTALITY; NOTE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

EID: 84874077074     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.01.016     Document Type: Editorial

References (26)

1. G.L. Armstrong, A. Wasley, E.P. Simard The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 2006 705 714
2. M.L. Volk, R. Tocco, S. Saini Public health impact of antiviral therapy for hepatitis C in the United States Hepatology 50 2009 1750 1755
3. P. Spradling, L. Rup, A.C. Moorman Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence Clin Infect Dis 55 2012 1047 1055
4. W.N. Southern, M.L. Drainoni, B.D. Smith Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting J Viral Hepat 18 2011 474 481
5. D.W. Roblin, B.D. Smith, C.M. Weinbaum Hepatitis C virus screening practices and prevalence in a managed care organization Am J Manag Care 17 2011 548 555
6. G.L. Armstrong, M.J. Alter, G.M. McQuillan The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States Hepatology 31 2000 777 782
7. G.L. Davis, M.J. Alter, H. El-Serag Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression Gastroenterology 138 2010 513 521
8. F. Kanwal, T. Hoang, J.R. Kramer Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection Gastroenterology 140 2011 1182 1188
9. A.J. van der Meer, B.J. Veldt, J.J. Feld Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis JAMA 308 2012 2584 2593
10. B.M. Spiegel, Z.M. Younossi, R.D. Hays Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment Hepatology 41 2005 790 800
11. E.J. Gane, C.A. Stedman, R.H. Hyland Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C N Engl J Med 368 2013 34 44
12. F. Poordad, E. Lawitz, K.V. Kowdley Exploratory study of oral combination antiviral therapy for hepatitis C N Engl J Med 368 2013 45 53
13. E.Y. Chen, S.N. Sinclair, F. Czul Triple therapy for hepatitis C infection in the real world: practice trends following the release of boceprevir and telaprevir (abstr) Hepatology 56 2012 259A
14. Centers for Disease Control and Prevention Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR 61 RR-4 2012 1 32
15. R. Chou, E.B. Cottrell, N. Wasson Screening for hepatitis C virus infection in adults: a systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation Ann Intern Med 2012 Nov 27 [Epub ahead of print]
16. G.H. Guyatt, A.D. Oxman, G. Vist GRADE Working Group Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
17. D.B. Rein, B.D. Smith, J.S. Wittenborn The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings Ann Intern Med 156 2012 263 270
18. N. Calonge, G. Randhawa U.S. Preventive Services Task Force The meaning of the U.S. Preventive Services Task Force grade I recommendation: screening for hepatitis C virus infection Ann Intern Med 141 2004 718 719
19. R.A. Gunn, P.J. Murray, C.H. Brennan Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project Sex Transm Dis 30 2003 340 344
20. T. McGinn, N. O'Connor-Moore, D. Alfandre Validation of a hepatitis C screening tool in primary care Arch Intern Med 168 2008 2009 2013
21. I.A. Zuniga, J.J. Chen, D.S. Lane Analysis of a hepatitis C screening programme for US veterans Epidemiol Infect 134 2006 249 257
22. F. Zuure, U. Davidovich, G. Kok Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population Euro Surveill 15 2010 19539
23. M.L. Drainoni, A.H. Litwin, B.D. Smith Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting Am J Public Health 102 2012 e115 e121
24. Institute of Medicine Report Hepatitis and liver cancer A national strategy for prevention and control of hepatitis B and C www.iom.edu/ viralhepatitis Accessed January 3, 2013
25. N. Freemantle, E.L. Harvey, F. Wolf Printed educational materials: effects on professional practice and health care outcomes Cochrane Database Syst Rev 2 2000 CD000172
26. B. McCormack, A. Kitson, G. Harvey Getting evidence into practice: the meaning of 'context' J Adv Nurs 38 2002 94 104